Search CommunityWalk:
Create_a_map_small
Mymaps_small



Blank

ImQuest Biosciences

Address:
7340 Executive Way
--
Frederick, MD 21704, USA
1-301-696-0274

Category: BioManufacturing; Research Services & Supplies; Suppliers (CRO)

Used in the following map:

Maryland Biotech Industry Map

ImQuest BioSciences is a contract research organization for the biotechnology and pharmaceutical industries. Its mission is to be the leading provider of services ranging from the discovery of anti - infective and anti - cancer drugs and vaccines through complete preclinical and clinical therapeutic development. The company was founded by Daniel R. Caffoe and Robert W. Buckheit in 2004.

ImQuest's range of programs and services include: anti-infectives, anti cancer, topical microbicides, formulation and development, technical services and professional services. It offers formulation work specializing in semi-solid and solid drug delivery formulation in the microbicide field. Its formulation capabilities include: oral dosage formulations, intravenous formulations, semi-solid formulation, film formulation and nanoparticle formulations. The company has the capabilities to develop and evaluated biodegradable nanoparticles for drug delivery. Its capabilities in nanoparticle formulation include: manufacturing of nanoparticles, drug encapsulation and characterization, in vitro dissolution and release of drug from nanoparticles, microscopy targeting of nanoparticles in vitro and ex vivo, and nanoparticle toxicity.

ImQuest's technical services include: microbiology and virology services, molecular biology services, tissue culture services, biochemistry services, enzymology services and immunology services. The company's microbicide development program utilizes a wide range of microbiological, biochemical and molecular technologies to assess the activity of agents against HIV, define the precise mechanism of action of potential microbicides using assays that closely mimics the microbicide environment, and analyze the potential toxicity of an inhibitor. It also provides professional services that include: grant and contract proposals, consulting support, R&D and therapeutic consulting services, IND preparation and submission, and regulatory compliance support.

ImQuest has agreements with National Institutes of Health, The U.S. Department of Health and Human Services, Aethlon Medical Inc, Arisyn Therapeutics, Inc., Samjin Pharmaceutical Co. Ltd.